Relay Therapeutics (RLAY) Change in Receivables (2021 - 2023)
Relay Therapeutics' (RLAY) quarterly Change in Receivables came in at -$211000.0 in Q4 2023, down 424.62% year-on-year from $65000.0 in Q4 2022, and down 258.65% on a QoQ basis from $133000.0 in Q3 2023.
Relay Therapeutics (RLAY) Change in Receivables (2021 - 2023) Analysis & Trends
Relay Therapeutics (RLAY) has 3 years of Change in Receivables data on file, last reported at -$211000.0 in Q4 2023.
- On a quarterly basis, Change in Receivables fell 424.62% year-over-year to -$211000.0 in Q4 2023; TTM through Dec 2023 was -$306000.0, a 215.46% decrease from a year earlier, with the FY2023 full-year figure at -$306000.0, down 215.46% from the prior year.
- Change in Receivables for Q4 2023 stood at -$211000.0, down from $133000.0 in the prior quarter.
- Over the last five years, Change in Receivables for RLAY reached as high as $525000.0 in Q3 2021 and fell as low as -$75.0 million in Q1 2021.
- Historically, Change in Receivables has averaged -$6.3 million across 3 years, with a median of -$33500.0 in 2022.
- On a YoY basis, Change in Receivables climbed as much as 382.98% in 2023 and fell as far as 1194.74% in 2023.
- Year by year, Change in Receivables stood at -$401000.0 in 2021, then soared by 116.21% to $65000.0 in 2022, then tumbled by 424.62% to -$211000.0 in 2023.
- Per Business Quant data, the three most recent Change in Receivables figures were -$211000.0 in Q4 2023, $133000.0 in Q3 2023, and -$208000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Relay Therapeutics | 3.43 Bn | 3.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -211,000.00 |
| Dec 31, 2023 | -211,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | -208,000.00 |
| Jun 30, 2023 | -208,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Mar 31, 2023 | -20,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | -47,000.00 |
| Sep 30, 2022 | -47,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | -134,000.00 |
| Mar 31, 2022 | -134,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Sep 30, 2021 | 525,000.00 |
| Sep 30, 2021 | 525,000.00 |